Teriparatide Injection, Solution
Product Images NDC 60505-6188
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Teriparatide (NDC 60505-6188). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton-label (Carton Label)
Figure-1 (Figure 1)
Figure-10 (Figure 10)
Figure-11 (Figure 11)
Figure-12 (Figure 12)
Figure-13 (Figure 13)
Figure-14 (Figure 14)
Figure-15 (Figure 15)
Figure-16 (Figure 16)
Figure-17 (Figure 17)
Caption-2 (Figure 19)
Figure-2 (Figure 2)
Figure-3 (Figure 3)
Figure-4 (Figure 4)
Figure-5 (Figure 5)
Figure-6 (Figure 6)
Figure-7 (Figure 7)
Figure-8 (Figure 8)
Figure-9 (Figure 9)
Injection-label (Injection Label)
Teriparatide Injection, USP is a medication that is administered subcutaneously once daily. Each dose contains 20 meg and is provided in a single-patient-use prefilled pen. The pen can deliver 28 subcutaneous doses in total. The concentration of the medication is 600 mcg/2.4 mL (250 meg/mL). It is important to not transfer the contents of the pen to a syringe and to read the User Manual before injecting. The medication should be refrigerated and not frozen. After the first use, the pen should be discarded after 28 days. This specific product is marketed by Apotex Corp, which is located in Weston, Florida. The product is manufactured in Canada.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.